Trademark: 79150591
Word
CTRS
Status Date
Friday, February 18, 2022
Registration Number
4783860
Registration Date
Tuesday, August 4, 2015
Filing Date
Thursday, April 10, 2014
Published for Opposition
Tuesday, May 19, 2015
Cancellation Date
Friday, February 18, 2022
5 Pharmaceutical products for the treatment of biliary insufficiency, cell therapy, inflammatory conditions and disease, hematological conditions and cancer; dietetic substances and foods for medical use, namely, drinks adapted for medical use; antibiotics; capsules for medicines, namely, capsules for treating biliary insufficiency, cell therapy, inflammatory conditions and disease, hematological conditions and cancer; stem cells for medical use; drugs for medical use, namely, pharmaceutical preparations for treating biliary insufficiency, cell therapy, inflammatory conditions and disease, hematological conditions and cancer; medicines for human medicine, namely, pharmaceutical preparations for treating biliary insufficiency, cell therapy, inflammatory conditions and disease, hematological conditions cancer; bacteriological preparations for medical purposes; biological preparations for medical use, namely, biological preparations for treating biliary insufficiency, cell therapy, inflammatory conditions and disease, hematological conditions and cancer; chemical preparations for medical or pharmaceutical use, namely, for treating biliary insufficiency, cell therapy, inflammatory conditions and disease, hematology and cancer; diagnostic products for medical use, namely, medical diagnostic reagents
44 Medical services related to biliary insufficiency, cell therapy, inflammatory conditions and disease, hematology and cancer; health counseling services related to biliary insufficiency, cell therapy, inflammatory conditions and disease, hematology and cancer; consultancy in the field of pharmaceutical products; medical information; information on pharmaceutical products; medical analysis services relating to the treatment of patients affected by biliary insufficiency, cell therapy, inflammatory conditions and diseases, hematology-related and cancer-related conditions and diseases; medical diagnostic services
42 Medical services featuring evaluations, estimates and research in the field of science; research and development in the field of medicine and biotechnology; research and development for others in the medical and pharmaceutical field; scientific laboratory services in the medical field; scientific research for medical purposes; biological research; bacteriological research; chemical research
The mark consists of the stylized blue wording "C T R S" appearing within an incomplete blue rectangle. A small red and white circle appears between the letters "T" and "R".
Blue applies to the letters CTRS and the frame; red (shaded from white to red) applies to the point located between the letters T and R.
The color(s) blue, red, and white is/are claimed as a feature of the mark.
Dec 20, 2022
Total Invalidation Processed By The Ib
Nov 18, 2022
Total Invalidation Of Reg Ext Protection Sent To Ib
Nov 18, 2022
Invalidation Processed
Oct 18, 2022
Total Invalidation Of Reg Ext Protection Created
Feb 18, 2022
Cancelled Section 71
Aug 4, 2020
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
May 7, 2020
New Representative At Ib Received
Nov 15, 2019
New Representative At Ib Received
Feb 5, 2016
Final Decision Transaction Processed By Ib
Jan 6, 2016
Final Disposition Notice Sent To Ib
Jan 6, 2016
Final Disposition Processed
Nov 4, 2015
Final Disposition Notice Created, To Be Sent To Ib
Aug 4, 2015
Registered-Principal Register
Jun 12, 2015
Notification Processed By Ib
Jun 6, 2015
New Representative At Ib Received
May 19, 2015
Official Gazette Publication Confirmation E-Mailed
May 19, 2015
Published For Opposition
Apr 29, 2015
Notification Of Possible Opposition Sent To Ib
Apr 29, 2015
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Apr 29, 2015
Notification Of Notice Of Publication E-Mailed
Apr 13, 2015
Law Office Publication Review Completed
Apr 11, 2015
Assigned To Lie
Mar 23, 2015
Approved For Pub - Principal Register
Feb 24, 2015
Teas/Email Correspondence Entered
Feb 24, 2015
Correspondence Received In Law Office
Feb 24, 2015
Teas Response To Office Action Received
Sep 11, 2014
Refusal Processed By Ib
Aug 27, 2014
Non-Final Action Mailed - Refusal Sent To Ib
Aug 27, 2014
Refusal Processed By Mpu
Aug 27, 2014
Non-Final Action (Ib Refusal) Prepared For Review
Aug 26, 2014
Non-Final Action Written
Aug 22, 2014
Application Filing Receipt Mailed
Aug 18, 2014
Assigned To Examiner
Aug 18, 2014
New Application Office Supplied Data Entered In Tram
Aug 15, 2014
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
